TrialThe oncologist2019

TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World.

Jonathan Strosberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.